About
About
Advancing Oncology Through Radiopharmaceutical Innovation
The Radiopharmaceutical Education Institute (RPEI) is a multidisciplinary educational platform dedicated to advancing the science and clinical integration of radiopharmaceutical therapies in oncology.
As radiopharmaceutical innovation reshapes the therapeutic landscape of cancer care, RPEI serves as a trusted resource for oncology clinicians seeking rigorous, evidence-based insights and cross-specialty perspectives. Our platform bridges oncology and nuclear medicine, fostering dialogue that supports informed clinical decision-making and prepares clinicians for the evolving era of theranostics.
Mission
The Radiopharmaceutical Education Institute (RPEI) is dedicated to advancing the science and clinical integration of radiopharmaceutical therapies in oncology. Through accessible, expert-driven education and multidisciplinary dialogue, we aim to equip clinicians with the insight and evidence needed to inform treatment decisions and shape the future of radiopharmaceutical innovation in cancer care.
Editorial Staff
Associate Editorial Director: Janelle Bradley
jbradley@hmpglobal.com
Managing Editor: Stephanie Holland
sholland@hmpglobal.com
Managing Editor: Kirra Fedyszyn
kfedyszyn@hmpglobal.com
Associate Editor: Emily Estrada
eestrada@hmpglobal.com
Business Staff
Director, Oncology Omnimedia Sales: Erin Statmore
estatmore@hmpglobal.com
Senior Manager, National Accounts: Stephanie Makowski
smakowski@hmpgobal.com
Digital Operations Staff
Director, Digital Revenue Operations: Katelynn McFadden
Assistant Director, Digital Operations: Nina Fischang
Senior Manager, Digital Operations: Addison Fish
Associate Manager, Digital Operations: Cady Cohen
Corporate Staff
Chief Executive Officer: Jeff Hennessy
Chief Financial Officer: Greg Salter
President & Chief Operating Officer: Jeff Hennessy, Jr.
Chief Strategy & Corporate Development Officer: Mark Miller
Chief HR Officer/Executive Vice President, Operations: Anthony Mancini
Senior Vice President, Content Development & Operations: David DePinho
Executive Vice President, Business Development & Product Strategy: Kara Rosania
Vice President, Information Technology: Tim Shaw
About Our Publisher
HMP Global is a healthcare events, education, and omnichannel engagement company that has served the clinical community for more than 40 years. Its portfolio spans 27 brands and 83 events, including Psych Congress, the Symposium on Advanced Wound Care (SAWC), EMS World Expo, NEI, LINC, and Advances in IBD, connecting more than 2 million healthcare professionals with over 6,000 leading experts.
HMP Global operates through: the HMP Global Learning Network and Consultant360 for clinical publishing, HMP Education for accredited continuing education, HMP Global Events for live events, and HMP Collective for year-round omnichannel clinician engagement. Its portfolio also includes the Neuroscience Education Institute (NEI) and Drug Channels Institute. To learn more, visit hmpglobal.com.
© 2026, HMP. All rights reserved. Reproduction in whole or in part prohibited. Opinions expressed by authors, contributors, and advertisers are their own and not necessarily those of HMP, the editorial staff, or any member of the editorial advisory board. HMP is not responsible for accuracy of dosages given in articles printed herein. The appearance of advertisements is not a warranty, endorsement or approval of the products or services advertised or of their effectiveness, quality or safety. Rapid advances in medicine may cause information contained here to become outdated, invalid or subject to debate. Accuracy cannot be guaranteed. HMP disclaims responsibility for any injury to persons or property resulting from any ideas or products referred to in the articles or advertisements. Content may not be reproduced in any form without written permission. Rights and Permission information is available at www.hmpglobal.com.
